title: Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: the authors' reply.
authors.affiliation: Hospital Universitario Central de Asturias, Departamento de Medicina, Universidad de Oviedo, Oviedo, Spain.
authors.forename: T
authors.initials: T
authors.lastname: Bernal
authors.affiliation: Hospital Universitario Central de Asturias, Departamento de Medicina, Universidad de Oviedo, Oviedo, Spain.|Universidad Autónoma de Chile, Santiago de Chile, Chile.
authors.forename: P
authors.initials: P
authors.lastname: Martínez-Camblor
authors.affiliation: IMIBIC, Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Sánchez-García
authors.affiliation: Hospital Universitario y Politécnico La Fe, Valencia, Spain.
authors.forename: G
authors.initials: G
authors.lastname: Sanz
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine